Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy

Journal of Clinical Sleep Medicine

Volumn 7, Issue 6, 2011, Pages 653-658

  Heier, Mona S ^a   Jansson, Tine S ^a   Gautvik, Kaare M ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Body mass index (BMI); Hypocretin; Leptin; Metabolism; Narcolepsy; Overweight

Indexed keywords

HEMOGLOBIN A1C; LEPTIN; OREXIN A;

ARTICLE; BODY MASS; CATAPLEXY; CLINICAL EXAMINATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; HYPERSOMNIA; IDIOPATHIC HYPERSOMNIA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NARCOLEPSY; NEUROLOGIC EXAMINATION; OBESITY; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL;

ADULT; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; CATAPLEXY; CAUSALITY; COMORBIDITY; FEMALE; HUMANS; HYPERSOMNOLENCE, IDIOPATHIC; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NARCOLEPSY; NEUROPEPTIDES; OBESITY; OVERWEIGHT; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 84855702980     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.1474     Document Type: Article

References (35)

1. Heier MS, Evsiukova T, Wilson, Abdelnoor M, Hublin C, Ervik S. Prevalence of narcolepsy with cataplexy in Norway. Acta Neurol Scand 2009;120:276-80.
2. Hublin C, Kaprio J, Partinen M, et al. The prevalence of narcolepsy: an epidemiological study of the Finnish twin cohort. Ann Neurol 1994;35:709-16. (Pubitemid 24172171)
3. Ohayon MM, Pries RG, Zulley J, Smirne S, Paiva T. Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology 2002;58:1826-33. (Pubitemid 34663586)
4. Silber M, Krahn L, Olson E, Pancratz S. The epidemiology of narcolepsy in Olmstedt County, Minnesota: a population-based study. Sleep 2002;25:197-202. (Pubitemid 34193581)
5. American Academy of Sleep Medicine. The international classification of sleep disorders, 2nd ed: diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine; 2005.
6. Gautvik KM, De Lecea L, Gautvik VT, et al. Overview of the most prevalent hypothalamus-specific mRNAs as identified by directional PCR subtraction. Proc Natl Acad Sci U S A 1996;93:8733-8 (Pubitemid 26269629)
7. De Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998;95:322-7. (Pubitemid 28103952)
8. Heier MS, Evsiukova T, Vilming S, Gjerstad MD, Schrader H, Gautvik K. CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway. Sleep 2007;30:969-73. (Pubitemid 47221896)
9. Mignot E, Lammers GJ, Ripley, B et al. The role of cerebrospinal fluid hypocretin measurements in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553-62.
10. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. CSF hypocretin/orexin deficiency in human narcolepsy. Lancet 2000;355:39-40. (Pubitemid 30072183)
11. Ripley B, Overeem S, Fujiki N, et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 2001;57:2253-58. (Pubitemid 34016460)
12. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:467-74.
13. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G-protein coupled receptors that regulate feeding behaviour. Cell 1998;92:573-85. (Pubitemid 28101119)
14. Sakurai T. Roles of orexins and orexin receptors in central regulation of feeding behaviour and energy homeostasis. CNS Neurol Disord Drug Targets 2006;5:313-25. (Pubitemid 43884171)
15. Poli F, Plazzi G, Di Dalmazi G, et al. Body mass index-independent metabolic alterations in narcolepsy with cataplexy. Sleep 2009;32:1491-7.
16. Honda Y, Doy Y, Ninomiya R, Ninomiua C. Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients. Sleep 1986;9:254-9. (Pubitemid 18008505)
17. Schuld A, Hebebrand J, Geller F, Pollmächer T. Increased body-mass index in patients with narcolepsy. Lancet 2000;355:1274-5. (Pubitemid 30184546)
18. Dahmen N, Bierbrauer J, Kasten M. Increased prevalence of obesity in narcoleptic patients and relatives. Eur Arch Psychiatry Clin Neurosci 2001;251;85-9. (Pubitemid 32488036)
19. Nishino S, Ripley B, Overeem S, et al. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 2001;50:381-8. (Pubitemid 32848741)
20. Dahmen N, Tonn P, Messoroghi L, Gheszel-Ahmadi D, Engel A. Basal metabolic rate in narcoleptic patients. Sleep 2009;32:962-4.
21. Chabas D, Foulon C, Gonzalez J, et al. Eating disorder and metabolism in narcoleptic patients. Sleep 2007;30:1267-73. (Pubitemid 47548277)
22. Arnulf I, Lin L, Zhang J, et al. CSF versus serum leptin in narcolepsy: Is there an effect of hypocretin deficiency? Sleep 2006;29:1017-24. (Pubitemid 44257378)
23. Fujiki N, Yoshida Y, Zhang S, et al. Sex difference in body weight gain and leptin signalling in hypocretin/orexin deficient mouse models. Peptides 2006;27:2326-31. (Pubitemid 44437559)
24. Håkanson M-L, de Lecea L, Sutcliffe JG, Yanagisawa M, Meister B. Leptin receptor-and STAT3-immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus. J Neuroendocrinol 1999;11:653-63. (Pubitemid 29338682)
25. Shuld A, Blum WF, Uhr M, et al. Reduced leptin levels in human narcolepsy. Neuroendocrinology 2000;72:195-8.
26. Kok SW, Meinders AE, Overeem S, Lammers GJ, Roelfsema F, Frölich M. Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans. J Clin Endocrinol Metab 2002;87:805-9. (Pubitemid 34158256)
27. Dahmen N, Engel A, Helfrich J, et al. Peripheral leptin levels in narcoleptic patients. Diabetes Tech Ther 2007;9:348-53. (Pubitemid 47340084)
28. Chabas D, Foulon C, Gonzales J, et al. Eating disorder and metabolism in narcoleptic patients. Sleep 2007;30:1267-73. (Pubitemid 47548277)
29. Fortuin HA, Swinkels S, Buitelaar J, et al. High prevalence of eating disorders in narcolepsy with cataplexy: a case control study. Sleep 2008;31:335-41. (Pubitemid 351536505)
30. Dahmen N, Becht J, Engel A, Thommes M, Tonn P. Prevalence of eating disorders and eating attacks in narcolepsy. Neuropsychiatr Dis Treat 2008;4:257-61. (Pubitemid 351460962)
31. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999;354:1435-39. (Pubitemid 29494756)
32. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004;1:e62.Published online 2004 December 7.
33. Bjorvatn B, Sagen I, Øyane N et al. The association between sleep duration, body mass index and metabolic measures in the Hordaland Health Study. J Sleep Res 2007;16:66-76.
34. Broughton R, Dunham W, Newman J, Lutley K, Duchesne P, Rivers M. Ambulatory 24 hour sleep-wake monitoring in narcolepsy-cataplexy compared to matched controls. Electroencephalogr Clin Neurophysiol 1988;70:473-81.
35. Baker TL, Guilleminault G, Nino-Murcia G, et al. comparative polysomnographic study of narcolepsy and idiopathic central nervous system hypersomnia. Sleep 1986;9:232-42. (Pubitemid 18008501)